These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 26887318

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
    Simithy J, Reeve N, Hobrath JV, Reynolds RC, Calderón AI.
    Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106
    [Abstract] [Full Text] [Related]

  • 3. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
    Mehra R, Rajput VS, Gupta M, Chib R, Kumar A, Wazir P, Khan IA, Nargotra A.
    J Chem Inf Model; 2016 May 23; 56(5):930-40. PubMed ID: 27149193
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
    Kumar M, Verma S, Sharma S, Srinivasan A, Singh TP, Kaur P.
    Chem Biol Drug Des; 2010 Sep 01; 76(3):277-84. PubMed ID: 20626408
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of novel antimicrobial compounds targeting Mycobacterium tuberculosis shikimate kinase using in silico hierarchical structure-based drug screening.
    Kawamoto S, Hori C, Taniguchi H, Okubo S, Aoki S.
    Tuberculosis (Edinb); 2023 Jul 01; 141():102362. PubMed ID: 37311288
    [Abstract] [Full Text] [Related]

  • 11. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
    Segura-Cabrera A, Rodríguez-Pérez MA.
    Bioorg Med Chem Lett; 2008 Jun 01; 18(11):3152-7. PubMed ID: 18486472
    [Abstract] [Full Text] [Related]

  • 12. Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition.
    Simithy J, Gill G, Wang Y, Goodwin DC, Calderón AI.
    Anal Chem; 2015 Feb 17; 87(4):2129-36. PubMed ID: 25629762
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA, Moon JY, Lee SC, Ryoo SW, Yoon MY.
    Biochim Biophys Acta; 2015 Oct 17; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments.
    Freitas de Freitas T, Roth CD, Abbadi BL, Hopf FSM, Perelló MA, de Matos Czeczot A, de Souza EV, Borsoi AF, Machado P, Bizarro CV, Basso LA, Timmers LFSM.
    J Comput Aided Mol Des; 2023 Mar 17; 37(3):117-128. PubMed ID: 36547753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.